{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:51Z","timestamp":1792786131687,"version":"4.5.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"2025 Research Project Grants Programme of the Miguel Hern\u00e1ndez University of Elche","award":["VITPROY25\/23"],"award-info":[{"award-number":["VITPROY25\/23"]}],"id":[{"id":"https:\/\/ror.org\/01azzms13","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize longitudinal glycated haemoglobin (HbA1c) trajectories before and after the diagnosis of type 2 diabetes and to evaluate their association with major cardiovascular events and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective population-based cohort study using Spanish electronic health records. Adults with incident type 2 diabetes diagnosed between 2005 and 2019 were included. Longitudinal HbA1c trajectories were modelled using functional principal component analysis and classified using Gaussian mixture modelling. The primary outcome was a composite of hospital admission for ischaemic heart disease, cerebrovascular disease, and all-cause mortality. Associations were assessed using adjusted Cox proportional hazards models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 264\u2009634 individuals with incident type 2 diabetes and 1\u2009719\u2009720 HbA1c measurements were included. Three distinct HbA1c trajectory classes were identified. Mean HbA1c values remained within the prediabetes range until ~10\u00a0years before diabetes diagnosis. The highest risk of the composite outcome was observed in the trajectory class with intermediate, rather than the highest, HbA1c levels. Compared with trajectory class 2, trajectory class 1 was associated with a substantially increased risk of the composite outcome in women (HR: 3.34, 95% CI: 3.18\u20133.50) and men (HR: 2.93, 95% CI: 2.81\u20133.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The trajectory associated with the greatest risk was not the one with the highest HbA1c levels, but the one characterized by greater baseline clinical vulnerability. The greatest impact of the associations falls on total mortality. These findings highlight the importance of considering long-term glycaemic patterns alongside clinical context when stratifying cardiovascular risk in people with type 2 diabetes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/postmj\/qgag124","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:18:43Z","timestamp":1788520723000},"source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal HbA1c trajectories and clinical prognosis in type 2 diabetes: a population-based cohort study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6947-7531","authenticated-orcid":false,"given":"Jose A","family":"Quesada","sequence":"first","affiliation":[{"name":"Cardiovascular Research Group (GRINCAVA), Clinical Medicine Department, School of Medicine, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Primary Care Research Center, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jose","family":"Pomares-Gomez","sequence":"additional","affiliation":[{"name":"Clinical Medicine Department, School of Medicine, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Department of Health of San Juan de Alicante, Endocrinology and Nutrition Section , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Esquerdo-Arroyo","sequence":"additional","affiliation":[{"name":"Primary Care Research Center, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Clinical Medicine Department, School of Medicine, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Alicante Institute for Health and Biomedical Research (ISABIAL) , Avda Pintor Baeza, 12 HGUA. Oficinas modulares, 03010 Alicante ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepcion","family":"Carratala-Munuera","sequence":"additional","affiliation":[{"name":"Primary Care Research Center, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Clinical Medicine Department, School of Medicine, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Alicante Institute for Health and Biomedical Research (ISABIAL) , Avda Pintor Baeza, 12 HGUA. Oficinas modulares, 03010 Alicante ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente F","family":"Gil-Guillen","sequence":"additional","affiliation":[{"name":"Primary Care Research Center, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Clinical Medicine Department, School of Medicine, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Alicante Institute for Health and Biomedical Research (ISABIAL) , Avda Pintor Baeza, 12 HGUA. Oficinas modulares, 03010 Alicante ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Orozco-Beltran","sequence":"additional","affiliation":[{"name":"Primary Care Research Center, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Clinical Medicine Department, School of Medicine, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2117-0178","authenticated-orcid":false,"given":"Adriana","family":"Lopez-Pineda","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Group (GRINCAVA), Clinical Medicine Department, School of Medicine, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Primary Care Research Center, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Clinical Medicine Department, School of Medicine, Miguel Hernandez University of Elche (UMH) , Crta. Nacional N-332 s\/n, 03550 Sant Joan d\u2019Alacant ,","place":["Spain"]},{"name":"Alicante Institute for Health and Biomedical Research (ISABIAL) , Avda Pintor Baeza, 12 HGUA. Oficinas modulares, 03010 Alicante ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2026091812365818300_ref1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.5327047","volume-title":"IDF Diabetes Atlas: Global, Regional and National Diabetes Prevalence Estimates for 2024 and Projections for 2050","author":"Genitsaridi","year":"2024"},{"key":"2026091812365818300_ref2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00125-011-2336-9","article-title":"Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es study","volume":"55","author":"Soriguer","year":"2012","journal-title":"Diabetologia."},{"key":"2026091812365818300_ref3","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(23)00001-6","article-title":"Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact","volume":"401","author":"Gregg","year":"2023","journal-title":"Lancet."},{"key":"2026091812365818300_ref4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-022-01516-6","article-title":"Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management","volume":"21","author":"Ma","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026091812365818300_ref5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2026091812365818300_ref6","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"2026091812365818300_ref7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet."},{"key":"2026091812365818300_ref8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"2026091812365818300_ref9","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"N Engl J Med"},{"key":"2026091812365818300_ref10","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"ADVANCE Collaborative Group","year":"2008","journal-title":"N Engl J Med"},{"key":"2026091812365818300_ref11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"2026091812365818300_ref12","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"Glycemic targets: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2026091812365818300_ref13","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"2026091812365818300_ref14","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation."},{"key":"2026091812365818300_ref15","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/pds.5006","article-title":"Base de datos para la investigaci\u00f3n farmacoepidemiol\u00f3gica en atenci\u00f3n primaria (BIFAP): A data resource for pharmacoepidemiology in Spain","volume":"29","author":"Maci\u00e1-Mart\u00ednez","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026091812365818300_ref16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/13814780902855754","article-title":"Diagnostic usefulness of the Alcohol Use Disorders Identification Test (AUDIT) questionnaire for detection of hazardous drinking and alcohol dependence among Spanish patients","volume":"15","author":"P\u00e9rula de Torres","year":"2009","journal-title":"Eur J Gen Pract"},{"key":"2026091812365818300_ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"Van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"2026091812365818300_ref18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1198\/016214504000001745","article-title":"Functional data analysis for sparse longitudinal data","volume":"100","author":"Yao","year":"2005","journal-title":"J Am Stat Assoc"},{"key":"2026091812365818300_ref19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1198\/016214502760047131","article-title":"Model-based clustering, discriminant analysis and density estimation","volume":"97","author":"Fraley","year":"2002","journal-title":"J Am Stat Assoc"},{"key":"2026091812365818300_ref20","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2025"},{"key":"2026091812365818300_ref21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.medcli.2011.06.026","article-title":"Relaci\u00f3n del grado de control gluc\u00e9mico con las caracter\u00edsticas de la diabetes y el tratamiento de la hiperglucemia en la diabetes tipo 2. Estudio DIABES","volume":"138","author":"P\u00e9rez","year":"2012","journal-title":"Med Clin (Barc)"},{"key":"2026091812365818300_ref22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pcd.2024.12.002","article-title":"Glycemic and weight control in people with type 2 diabetes: a real-world observational study in primary care","volume":"19","author":"Orozco-Beltran","year":"2025","journal-title":"Prim Care Diabetes"},{"key":"2026091812365818300_ref23","doi-asserted-by":"publisher","first-page":"111722","DOI":"10.1016\/j.diabres.2024.111722","article-title":"Longitudinal HbA1c patterns before the first treatment of diabetes in routine clinical practice: a latent class trajectory analysis","volume":"212","author":"Nicolaisen","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091812365818300_ref24","doi-asserted-by":"publisher","first-page":"e0275610","DOI":"10.1371\/journal.pone.0275610","article-title":"Longitudinal HbA1c trajectory modelling reveals the association of HbA1c and risk of hospitalization for heart failure in patients with type 2 diabetes mellitus","volume":"18","author":"Tee","year":"2023","journal-title":"PLoS One"},{"key":"2026091812365818300_ref25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.pcd.2019.11.009","article-title":"Distinct trajectories in HbA1c are associated with different all-cause mortality and morbidity in newly diagnosed patients with type 2 diabetes","volume":"14","author":"Hemo","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"2026091812365818300_ref26","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.2337\/dc11-1793","article-title":"Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7)","volume":"35","author":"Heianza","year":"2012","journal-title":"Diabetes Care"},{"key":"2026091812365818300_ref27","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1111\/dom.15856","article-title":"Trajectory of haemoglobin A1c and incidence of cardiovascular disease in patients with type 2 diabetes mellitus","volume":"26","author":"Wang","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026091812365818300_ref28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00592-023-02037-8","article-title":"Long-term HbA1c variability and macro- and microvascular complications in type 2 diabetes mellitus: a meta-analysis update","volume":"60","author":"Sartore","year":"2023","journal-title":"Acta Diabetol"},{"key":"2026091812365818300_ref29","doi-asserted-by":"publisher","first-page":"e1919666","DOI":"10.1001\/jamanetworkopen.2019.19666","article-title":"Association of longitudinal values of glycated hemoglobin with cardiovascular events in patients with type 2 diabetes and multivessel coronary artery disease","volume":"3","author":"Rezende","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026091812365818300_ref30","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s00125-019-4939-5","article-title":"Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course","volume":"62","author":"Huebschmann","year":"2019","journal-title":"Diabetologia."},{"key":"2026091812365818300_ref31","doi-asserted-by":"publisher","first-page":"20406223211026391","DOI":"10.1177\/20406223211026391","article-title":"HbA1c trajectory and cardiovascular outcomes: an analysis of data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study","volume":"12","author":"Wang","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"2026091812365818300_ref32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pcd.2025.11.012","article-title":"Routine HbA1c monitoring and cardiovascular outcomes in diabetes: evidence from a large Spanish cohort","volume":"20","author":"Orozco-Beltran","year":"2026","journal-title":"Prim Care Diabetes"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/advance-article-pdf\/doi\/10.1093\/postmj\/qgag124\/71226757\/qgag124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/advance-article-pdf\/doi\/10.1093\/postmj\/qgag124\/71226757\/qgag124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:37:06Z","timestamp":1789749426000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/advance-article\/doi\/10.1093\/postmj\/qgag124\/8817375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1093\/postmj\/qgag124","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"qgag124"}}